Literature DB >> 32640193

Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation.

Sang Bae Lee1, Aram Ko1, Young Taek Oh1, Peiguo Shi1, Fulvio D'Angelo1, Brulinda Frangaj1, Antonius Koller2, Emily I Chen2, Timothy Cardozo3, Antonio Iavarone4, Anna Lasorella5.   

Abstract

Activation of dual-specificity tyrosine-phosphorylation-regulated kinases 1A and 1B (DYRK1A and DYRK1B) requires prolyl hydroxylation by PHD1 prolyl hydroxylase. Prolyl hydroxylation of DYRK1 initiates a cascade of events leading to the release of molecular constraints on von Hippel-Lindau (VHL) ubiquitin ligase tumor suppressor function. However, the proline residue of DYRK1 targeted by hydroxylation and the role of prolyl hydroxylation in tyrosine autophosphorylation of DYRK1 are unknown. We found that a highly conserved proline in the CMGC insert of the DYRK1 kinase domain is hydroxylated by PHD1, and this event precedes tyrosine autophosphorylation. Mutation of the hydroxylation acceptor proline precludes tyrosine autophosphorylation and folding of DYRK1, resulting in a kinase unable to preserve VHL function and lacking glioma suppression activity. The consensus proline sequence is shared by most CMGC kinases, and prolyl hydroxylation is essential for catalytic activation. Thus, formation of prolyl-hydroxylated intermediates is a novel mechanism of kinase maturation and likely a general mechanism of regulation of CMGC kinases in eukaryotes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32640193      PMCID: PMC7849370          DOI: 10.1016/j.molcel.2020.06.021

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  58 in total

Review 1.  HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus.

Authors:  G L Semenza
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

Review 2.  Prolyl 4-hydroxylase.

Authors:  Kelly L Gorres; Ronald T Raines
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

3.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

4.  Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.

Authors:  Natarajan Kannan; Andrew F Neuwald
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

5.  Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates.

Authors:  Matthew E Cockman; Kerstin Lippl; Ya-Min Tian; Johanna Myllyharju; Christopher J Schofield; Peter J Ratcliffe; Hamish B Pegg; William D Figg; Martine I Abboud; Raphael Heilig; Roman Fischer
Journal:  Elife       Date:  2019-09-10       Impact factor: 8.140

6.  Systematic functional prioritization of protein posttranslational modifications.

Authors:  Pedro Beltrao; Véronique Albanèse; Lillian R Kenner; Danielle L Swaney; Alma Burlingame; Judit Villén; Wendell A Lim; James S Fraser; Judith Frydman; Nevan J Krogan
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

7.  A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).

Authors:  Anne L Ashford; David Oxley; Jason Kettle; Kevin Hudson; Sylvie Guichard; Simon J Cook; Pamela A Lochhead
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

8.  Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.

Authors:  Meera Soundararajan; Annette K Roos; Pavel Savitsky; Panagis Filippakopoulos; Arminja N Kettenbach; Jesper V Olsen; Scott A Gerber; Jeyanthy Eswaran; Stefan Knapp; Jonathan M Elkins
Journal:  Structure       Date:  2013-05-09       Impact factor: 5.006

9.  Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.

Authors:  Rie Sonamoto; Isao Kii; Yuka Koike; Yuto Sumida; Tomoe Kato-Sumida; Yukiko Okuno; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

10.  Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways.

Authors:  Javier Rodriguez; Ruth Pilkington; Amaya Garcia Munoz; Lan K Nguyen; Nora Rauch; Susan Kennedy; Naser Monsefi; Ana Herrero; Cormac T Taylor; Alex von Kriegsheim
Journal:  Cell Rep       Date:  2016-03-10       Impact factor: 9.423

View more
  10 in total

Review 1.  The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.

Authors:  Silvia Strocchi; Francesca Reggiani; Giulia Gobbi; Alessia Ciarrocchi; Valentina Sancisi
Journal:  Oncogene       Date:  2022-06-15       Impact factor: 8.756

Review 2.  Roles of HIF and 2-Oxoglutarate-Dependent Dioxygenases in Controlling Gene Expression in Hypoxia.

Authors:  Julianty Frost; Mark Frost; Michael Batie; Hao Jiang; Sonia Rocha
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

Review 3.  Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond.

Authors:  Florentin Pastor; Lulzim Shkreta; Benoit Chabot; David Durantel; Anna Salvetti
Journal:  Front Microbiol       Date:  2021-03-29       Impact factor: 5.640

Review 4.  Emerging roles of DYRK2 in cancer.

Authors:  Vasudha Tandon; Laureano de la Vega; Sourav Banerjee
Journal:  J Biol Chem       Date:  2021-01-07       Impact factor: 5.157

5.  Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B.

Authors:  Marco Papenfuss; Svenja Lützow; Gerrit Wilms; Aaron Babendreyer; Maren Flaßhoff; Conrad Kunick; Walter Becker
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

6.  Isc10, an inhibitor of the Smk1 MAPK, prevents activation loop autophosphorylation and substrate phosphorylation through separate mechanisms.

Authors:  Abhimannyu Rimal; Thomas M Swayne; Zeal P Kamdar; Madison A Tewey; Edward Winter
Journal:  J Biol Chem       Date:  2022-09-03       Impact factor: 5.486

Review 7.  Hydroxyproline in animal metabolism, nutrition, and cell signaling.

Authors:  Shengdi Hu; Wenliang He; Guoyao Wu
Journal:  Amino Acids       Date:  2021-08-03       Impact factor: 3.520

Review 8.  Role of Hypoxia in the Control of the Cell Cycle.

Authors:  Jimena Druker; James W Wilson; Fraser Child; Dilem Shakir; Temitope Fasanya; Sonia Rocha
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 6.208

Review 9.  Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview.

Authors:  Mattias F Lindberg; Laurent Meijer
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

Review 10.  Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment.

Authors:  Ruth Belostotsky; Yaacov Frishberg
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.